CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in KYMR — Kymera Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$60,744,024
+$19,493,653 QoQ
Shares Held
529,729
+7.0% QoQ
Ownership
0.637%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 273 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. KYMR ranks #30 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in KYMR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,744,024 | 529,729 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $41,250,371 | 495,262 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,673,593 | 497,026 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $24,894,095 | 439,825 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $18,734,826 | 429,304 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,447,347 | 381,708 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $15,576,533 | 387,187 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $17,362,584 | 366,841 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $11,196,764 | 375,101 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $14,235,061 | 354,106 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $7,808,378 | 306,692 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,194,199 | 301,741 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,922,334 | 301,102 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8,844,466 | 298,497 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,435,783 | 297,908 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,064,251 | 278,560 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,051,311 | 256,542 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,803,322 | 255,277 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $15,779,423 | 248,534 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $14,287,036 | 243,225 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $5,047,686 | 104,076 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,426,729 | 62,448 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,802,708 | 61,334 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||